|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +0.79% | -6.16% | -7.71% | +18.87% | +62.91% | +49.32% | +74.50% | +5.10% | - | 66.34B | |
| -0.53% | +6.08% | +13.16% | +10.11% | +15.47% | +11.21% | +89.56% | -17.31% | +235.86% | 52.92B | |
| -0.74% | +3.78% | -10.78% | +1.87% | +8.04% | +6.37% | +71.75% | +204.64% | +5,175.20% | 54.82B | |
| +0.74% | +2.75% | +0.54% | +31.36% | +18.83% | +26.31% | +45.29% | +6.49% | +259.92% | 44.09B | |
| +3.87% | +10.15% | +9.59% | +23.80% | +26.56% | +20.69% | +132.73% | +3.19% | +1,065.86% | 43.72B | |
| +7.91% | +4.30% | +2.93% | +8.96% | +146.77% | +263.91% | +602.72% | +629.86% | - | 42.13B | |
| -0.40% | +9.85% | +10.03% | +14.37% | +14.51% | +17.04% | +59.17% | +9.63% | +167.54% | 33.96B | |
| -1.54% | -0.92% | -7.02% | +26.94% | +56.74% | +36.81% | +6.78% | -56.43% | - | 26.17B | |
| +0.17% | +5.16% | +15.44% | +40.84% | +28.71% | +36.03% | +25.86% | -11.44% | +129.87% | 23.37B | |
| +2.20% | +2.43% | -5.09% | -1.07% | -4.23% | -15.54% | +0.29% | -66.16% | - | 22.9B | |
| +0.40% | -1.16% | -20.27% | -10.61% | -45.03% | -43.02% | +281.46% | +258.18% | +579.96% | 20.89B | |
| +0.45% | +2.06% | +1.65% | +17.90% | +10.82% | +14.33% | +171.51% | +230.99% | +1,913.68% | 17.37B | |
| +2.73% | +8.20% | +10.33% | +15.96% | +46.91% | +86.42% | +205.02% | +197.55% | +448.47% | 15.95B | |
| +0.86% | +2.26% | +2.00% | +14.30% | +27.60% | +27.39% | +68.87% | -23.44% | +87.03% | 15.41B | |
| +1.90% | +4.98% | -1.01% | -6.92% | - | - | - | - | - | 15.39B | |
| -1.70% | -0.86% | -2.12% | -1.70% | +172.60% | +149.75% | +358.65% | +1,398.21% | +710.15% | 14.65B | |
| +5.14% | +5.49% | +13.45% | +43.58% | +58.14% | +71.31% | +70.14% | -25.15% | +280.06% | 15.06B | |
| +0.77% | +7.87% | -4.84% | -7.80% | +20.24% | +0.13% | +554.55% | - | - | 14.25B | |
| +3.60% | +5.99% | +6.14% | +4.82% | -4.41% | -7.57% | -23.17% | -36.96% | +105.58% | 13.44B | |
| Average | +1.40% | +1.91% | +1.39% | +12.92% | +36.73% | +41.72% | +155.31% | +159.23% | +858.40% | 27.64B | |
| Weighted average by Cap. | +1.33% | +2.01% | +0.96% | +14.21% | +37.61% | +44.18% | +142.71% | +127.07% | +1,183.79% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
